News & Events
Phosphorex Welcomes NOF CORPORATION as Shareholder and Strategic Partner
Hopkinton, MA and Tokyo – August 9, 2024– Phosphorex, a drug delivery-focused contract development and manufacturing organization (“CDMO”) backed by Boston-based private equity firm Ampersand Capital Partners, announced today that NOF CORPORATION has completed a strategic investment into the company.
Aug 9, 2024
Phosphorex and NOF CORPORATION Collaborate to Supply Lipid Nanoparticle Formulations using NOF's Proprietary Ionizable Lipid, COATSOME® SS Series
HOPKINTON, Mass. and TOKYO, April 30, 2024 /PRNewswire/ -- Phosphorex, an Ampersand Capital Partners company and drug delivery-focused contract development and manufacturing organization (“CDMO”), announced today a collaboration with NOF CORPORATION to supply its global clients with NOF’s COATSOME® SS Series proprietary ionizable lipids, further enhancing its leading position in providing lipid nanoparticle (LNP)-based drug delivery solutions to the market.
Apr 30, 2024